表紙
市場調查報告書
商品編碼
1069448

免疫吸附設備的全球市場:現狀分析與預測(2021年∼2027年)

Immunoadsorption Devices Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 273 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球免疫吸附設備的市場規模,在預測期間(2021年∼2027年)預計將展現大幅成長。

由於心臟、神經和皮膚疾病數量的增加以及對免疫吸附技術在膿毒症等新領域的使用的關注,對免疫吸附劑的需求不斷增加。

本報告提供全球免疫吸附設備市場的相關調查,提供市場摘要,市場洞察,市場機會,競爭模式,企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 限制
  • 相關利益者
  • 報告所使用的貨幣

第2章 調查手法或假設

  • 免疫吸附設備市場調查流程
  • 免疫吸附設備市場調查手法
  • 預測方法
  • 受訪者簡介
  • 免疫吸附設備市場調查的主要目的

第3章 市場摘要

第4章 摘要整理

第5章 全球免疫吸附設備市場COVID-19影響

第6章 全球免疫吸附設備市場收益(100萬美元)(2019年∼2027年)

第7章 市場洞察:各類型

  • 選擇性
  • 半選擇性
  • 非選擇性
  • 其他

第8章 市場洞察:各產品

  • Toxipak
  • PentraSorb CRP
  • Glycosorb ABO
  • IgEnio
  • DALI
  • MONET
  • IMMUSORBA TR
  • Immunsorba
  • TheraSorb
  • Selesorb
  • Oxiris
  • CytoSorb
  • Toraymyxin
  • Seraph
  • Alteco LPS Adsorber
  • 其他

第9章 市場洞察:各治療領域

  • 心臟病
  • 神經學
  • 移植
  • 肝臟
  • 其他

第10章 市場洞察:各地區

  • 北美的免疫吸附設備市場
    • 美國
    • 加拿大
    • 其他的北美
  • 歐洲的免疫吸附設備市場
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區的免疫吸附設備市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他的亞太地區
  • 其他

第11章 免疫吸附設備市場市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 免疫吸附設備的市場機會

第13章 免疫吸附設備的市場趨勢

第14章 相關法規

第15章 需求與供給面的分析

  • 需求面分析
  • 供給面分析
    • 主要產品的銷售
    • 主要企業的夥伴關係
    • 主要企業的擴大,投資及出售
    • 主要的合併和收購

第16章 價值鏈分析

第17章 競爭模式

  • 競爭情形
    • 波特五力分析
    • 企業佔有率:各收益

第18章 企業概要

  • Pocard Ltd.
  • Pentracor GmbH
  • Glycorex Transplantation AB
  • Fresenius Medical Care
  • Asahi Kasei Medical Device
  • Miltenyi Biotec
  • Kaneka Medical Product
  • Baxter International Inc.
  • CytoSorbents Europe GmbH
  • Toray Medical Co. Ltd.

第19章 免責聲明

目錄
Product Code: UMHE21726

The global immunoadsorption devices market is expected to showcase significant growth during the forecast period (2021-2027). Immunoadsorption is an extracorporeal technique used for the removal of specific blood group antibodies and molecules from the blood. Currently, a large and different number of devices or columns each with a different active component to which the molecule of interest attaches, thereby allowing for selectivity in the molecules removed. The ability to select a different type of device for different conditions makes the immunoadsorption's significant advantages over other apheresis techniques, in that it negates the need for replacement of factors such as albumin and plasma. For instance, Pocard's Toxipak is a selective immunoadsorption device used in sepsis and sepsis shock where another selective immunoadsorption device Gylcosorb ABO is used in ABO compatibility. Rising cases of cardiology, neurology, dermatology, couple with increasing focus on the use of immunoadsorption technique in new areas like sepsis is increasing the demand of immunoadsorption devices.

Insights Presented in the Report

"Amongst type, selective segment held prominent share in the market in 2020."

Based on type, the market is categorized into selective, semi-selective, non-selective, and others. Among these, selective category held the considerable market share and is expected to continue its performance during the forecast period. This can be attributed to the presence of large number of immunoadsorption devices like Toxipak, Pentrasorb CRP, Miro, Glycosorb ABO, ABO Adsopak, Coraffin, IgEnio, DALI, Monet, and LDL lipopak. Further, selective immunoadsorption device helps in selectively target the molecules without disturbing other molecules, thereby it is commonly used in autoimmune conditions and transplantation.

"Amongst therapeutic area, cardiology segment accounted for major share in the global immunoadsorption devices market

Based on therapeutic area, the market is categorized into cardiology, neurology, transplant, kidney, and others. Among these, cardiology held the considerable share in the market owing to large number of cardiovascular cases. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally. In 2019, representing 32% of all global deaths. Further, increasing geriatric population and changing lifestyle is likely to increase the case in the foreseeable future. This in turn is expected to propel the demand of immunoadsorption devices.

"North America captured significant position in the Immunoadsorption Devices market"

For a better understanding of the market adoption of Immunoadsorption Devices, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America accounted for significant share in the market and is expected to showcase substantial growth during the forecast period owing developed healthcare infrastructure, large expenditure in the healthcare industry couple with adoption of new technologies in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive country level analysis of the industry

Customization Options:

The global immunoadsorption devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Immunoadsorption Devices Market
  • 2.2. Research Methodology of the Immunoadsorption Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Immunoadsorption Devices Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL IMMUNOADSORPTION DEVICES MARKET COVID-19 IMPACT

6 GLOBAL IMMUNOADSORPTION DEVICES MARKET REVENUE (USD MN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Selective
  • 7.2. Semi-Selective
  • 7.3. Non-Selective
  • 7.4. Others

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. Toxipak
  • 8.2. PentraSorb CRP
  • 8.3. Glycosorb ABO
  • 8.4. IgEnio
  • 8.5. DALI
  • 8.6. MONET
  • 8.7. IMMUSORBA TR
  • 8.8. Immunsorba
  • 8.9. TheraSorb
  • 8.10. Selesorb
  • 8.11. Oxiris
  • 8.12. CytoSorb
  • 8.13. Toraymyxin
  • 8.14. Seraph
  • 8.15. Alteco LPS Adsorber
  • 8.16. Others

9 MARKET INSIGHTS BY THERAPEUTIC AREA

  • 9.1. Cardiology
  • 9.2. Neurology
  • 9.3. Transplant
  • 9.4. Kidney
  • 9.5. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Immunoadsorption Devices Market
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Immunoadsorption Devices Market
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. United Kingdom
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia Pacific Immunoadsorption Devices Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Rest of World Immunoadsorption Devices Market

11 IMMUNOADSORPTION DEVICES MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 IMMUNOADSORPTION DEVICES MARKET OPPORTUNITIES

13 IMMUNOADSORPTION DEVICES MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis
    • 15.2.1. Top Product Launches
    • 15.2.2. Top Business Partnerships
    • 15.2.3. Top Business Expansions, Investments and Divestitures
    • 15.2.4. Top Merger and Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis
      • 17.1.1.1. Bargaining Power of Buyer
      • 17.1.1.2. Bargaining Power of Supplier
      • 17.1.1.3. Intensity of Rivalry
      • 17.1.1.4. Threats of New Entrant
      • 17.1.1.5. Threat of Substitute
    • 17.1.2. Company Shares, by Revenue

18 COMPANY PROFILED

  • 18.1. Pocard Ltd.
  • 18.2. Pentracor GmbH
  • 18.3. Glycorex Transplantation AB
  • 18.4. Fresenius Medical Care
  • 18.5. Asahi Kasei Medical Device
  • 18.6. Miltenyi Biotec
  • 18.7. Kaneka Medical Product
  • 18.8. Baxter International Inc.
  • 18.9. CytoSorbents Europe GmbH
  • 18.10. Toray Medical Co. Ltd.

19 DISCLAIMER